Article info

Download PDFPDF

A phase II clinical trial of adoptive transfer of haploidentical natural killer cells for consolidation therapy of pediatric acute myeloid leukemia

Authors

  1. a Rosa.Nguyen{at}STJUDE.ORG
  2. b Huiyun.Wu{at}STJUDE.ORG
  3. c Stanley.Pounds{at}STJUDE.ORG
  4. d Hiroto.Inaba{at}STJUDE.ORG
  5. e Raul.Ribeiro{at}STJUDE.ORG
  6. f David.Cullins{at}STJUDE.ORG
  7. g Barbara.Rooney{at}STJUDE.ORG
  8. h Teresa.Bell{at}STJUDE.ORG
  9. i lacayon{at}stanford.edu
  10. j Kenneth.heym{at}cookchildrens.org
  11. k barbara_degar{at}dfci.harvard.edu
  12. l dschiff{at}rchsd.org
  13. m William.Janssen{at}STJUDE.ORG
  14. n Brandon.Triplett{at}STJUDE.ORG
  15. o Ching-Hon.Pui{at}STJUDE.ORG
  16. p leungwing{at}att.net
  17. q 901-595-2388 Jeffrey.Rubnitz{at}STJUDE.ORG
View Full Text

Citation

Nguyen R, Wu H, Pounds S, et al
A phase II clinical trial of adoptive transfer of haploidentical natural killer cells for consolidation therapy of pediatric acute myeloid leukemia

Publication history

  • Received October 31, 2018
  • Accepted March 12, 2019
  • First published March 20, 2019.
Online issue publication 
January 08, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.